Showing results (291-300 of 306) with videos related to

Sort By:
Pageof 31
Cell Host & Microbe|August 28, 2021
Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumorsAna Montalban-Arques, Egle Katkeviciute, Philipp Busenhart, et al.
Immunity|December 13, 2023
Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disordersC Matthias Wilk, Flurin Cathomas, Orsolya Török, et al.
Nature Communications|November 19, 2021
Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunityIrene A Abela, Chloé Pasin, Magdalena Schwarzmüller, et al.
Blood|January 5, 2017
Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AMLBob Löwenberg, Thomas Pabst, Johan Maertens, et al.
Leukemia Research|October 3, 2015
Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomideFabian Beier, Behzad Kharabi Masouleh, Guntram Buesche, et al.
Blood Advances|September 11, 2020
Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDSGerwin Huls, Dana A Chitu, Thomas Pabst, et al.
Life Science Alliance|June 25, 2020
EBV renders B cells susceptible to HIV-1 in humanized miceDonal McHugh, Renier Myburgh, Nicole Caduff, et al.
Blood Cancer Journal|June 19, 2023
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabineJacobien R Hilberink, Isabelle A van Zeventer, Dana A Chitu, et al.
Haematologica|April 30, 2025
Different features of acute myeloid leukemia stem cell quantification in intensively treated patientsLok Lam Ngai, Tom Reuvekamp, Diana Hanekamp, et al.
Nature Communications|October 31, 2024
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemiaRebekka Wegmann, Ximena Bonilla, Ruben Casanova, et al.
Pageof 31